Table 3 Comparison of differences regarding evaluation of QoL domains by patients and family caregivers in intervention and control samples during first and second measurements

41.2 (16.2)

35.8 (15.7)

−5.4

< 0.001

43.4 (16.2)

46.3 (18.3)

2.9

0.125

52.6 (21.9)

50.0 (19.9)

−2.6

0.021

52.2 (21.9)

51.7 (23.1)

−0.6

0.837

40.9 (19.4)

33.9 (19.2)

−7.0

< 0.001

43.3 (16.7)

43.9 (17.7)

0.6

0.747

47.1 (17.1)

43.5 (14.7)

−3.6

< 0.001

47.8 (16.8)

50.1 (17.3)

2.3

0.159

50.2 (18.1)

46.6 (19.1)

−3.6

0.001

51.8 (19.0)

53.7 (19.2)

1.9

0.178

42.2 (15.6)

42.8 (14.6)

0.6

0.260

43.2 (13.9)

45.3 (15.1)

2.1

0.112

4.5 (1.6)

5.3 (1.7)

0.8

< 0.001

4.4 (1.6)

4.6 (1.9)

0.2

0.457

4.2 (1.5)

4.9 (1.5)

0.7

< 0.001

4.5 (1.7)

4.7 (1.8)

0.2

0.303

8.8 (7.7)

6.1 (6.8)

−2.7

< 0.001

9.4 (5.7)

9.4 (6.4)

0.0

0.735

34.5 (25.6)

25.1 (22.4)

−9.4

< 0.001

27.1 (24.3)

23.2 (21.6)

−3.9

0.691

31.6 (24.3)

25.5 (21.8)

−6.1

< 0.001

33.6 (18.3)

33.7 (20.2)

0.1

0.693

45.6 (19.6)

40.8 (17.7)

−4.8

< 0.001

40.5 (14.7)

41.7 (18.5)

1.2

0.348

30.6 (20.7)

26.2 (20.4)

−4.4

0.003

30.8 (17.6)

32.4 (17.5)

1.6

0.421

38.7 (19.1)

40.0 (18.1)

1.3

0.107

40.7 (15.5)

40.4 (17.0)

−0.3

0.739

6.7 (2.3)

7.3 (2.0)

0.6

< 0.001

6.2 (2.2)

6.3 (1.9)

0.1

0.661

6.9 (2.3)

7.4 (2.1)

0.5

< 0.001

6.2 (2.2)

6.3 (1.9)

0.1

0.699